What to Expect in 2022
What to Expect in 2022
Gladstone virologists discuss Omicron and what we might expect in 2022 from the COVID-19 pandemic
Gladstone Experts COVID-19 Greene Lab Ott Lab61 - 75 of 246 Results Clear All
Gladstone virologists discuss Omicron and what we might expect in 2022 from the COVID-19 pandemic
Gladstone Experts COVID-19 Greene Lab Ott LabGladstone scientists develop a single-dose intranasal treatment that is effective against variants of the SARS-CoV-2 virus
News Release Research (Publication) COVID-19 Virology Weinberger Lab Chaturvediabc7 News—Senior Investigators Warner Greene, MD, PhD, and Nevan Krogan, PhD, discuss the possibility that Omicron, although more transmissible than previous SARS-CoV-2 variants, may cause less severe disease.
Gladstone Experts COVID-19 Center for HIV Cure Research Data Science and Biotechnology Virology Greene Lab Krogan LabSan Francisco Chronicle—The identification of an individual infected with the Omicron variant of SARS-CoV-2 in San Francisco is helping local scientists assess the danger posed by the virus. Melanie Ott, director of the Gladstone Institute of Virology, explains that experiments using virus samples from that individual could help determine how well the available vaccines hold up to Omicron’s mutations.
Gladstone Experts COVID-19 Virology Ott LabSan Francisco Chronicle—The emerging Omicron variant of SARS-CoV-2 features several mutations in its spike protein that in theory could make it resistant to current vaccines. But Associate Investigator Nadia Roan, PhD, explains that current vaccines will still protect against Omicron, as they elicit a variety of antibodies and immune T cells that target non-mutated areas of spike.
Gladstone Experts COVID-19 Virology Roan LabABC News—A new variant of SARS-CoV-2, dubbed Omicron, is causing concern around the world. Gladstone President Deepak Srivastava explains that some of the variant’s 50 mutations may have arisen when an individual who was already immunocompromised became infected with the virus. Senior Investigator Nevan Krogan describes how his group is investigating whether the new mutations will change the ability of the virus to enter cells and cause disease.
Gladstone Experts COVID-19 Data Science and Biotechnology Virology Krogan Lab Srivastava LabNIH Director’s Blog—The Delta variant of SARS-CoV-2 is driving the latest surge of COVID-19 cases in the United States. New research from Senior Investigators Jennifer Doudna and Melanie Ott explains how mutations in this variant increase transmissibility.
Gladstone Experts COVID-19 Virology Doudna Lab Ott LabScientific American—There is increasing evidence that some people who recover from COVID-19 suffer from lingering heart problems, a phenomenon known as post-COVID-19 cardiac syndrome. Senior Investigator Bruce Conklin explains that it’s important to investigate the long-term consequences of infection, and describes his team’s work showing that infecting heart cells with SARS-CoV-2 can result in dramatic structural damage.
Gladstone Experts COVID-19 Cardiovascular Disease Conklin LabSan Francisco Chronicle—Associate Investigator Nadia Roan, PhD, comments on a potentially new type of COVID-19 vaccine that would fight the virus at its points of entry—the nose, throat, or lungs—and may provide even better protection than current shots in the arm.
Gladstone Experts COVID-19 Virology Roan LabSan Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, puts the CDC's definition of "fully vaccinated" in the context of our constantly evolving understanding of the COVID-19 pandemic.
Gladstone Experts COVID-19 Center for HIV Cure Research Virology Greene LabGladstone virologists discuss the state of the pandemic and how to stay safe this holiday season
COVID-19 Greene Lab Ott LabSan Francisco Chronicle—Associate Investigator Nadia Roan, PhD, explains that people who receive COVID-19 vaccination after having had the disease harbor special immune cells that may provide stronger and more durable protection against future infections.
Gladstone Experts COVID-19 Virology Roan LabUSA Today—Senior investigator Warner Greene, MD, PhD, comments on the benefits of vaccination after COVID-19 illness.
Gladstone Experts COVID-19 Center for HIV Cure Research Virology Greene LabABC7 News—Gladstone President Deepak Srivastava, MD, and Senior Investigator Nevan Krogan, PhD, compare and contrast vaccines to Merck's new drug against COVID-19.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Krogan Lab Srivastava LabGladstone researchers studied how T cells respond to COVID-19 vaccines over the weeks following immunization
News Release Research (Publication) COVID-19 Virology Roan Lab